Gaviscon Advance Oral Suspension *

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14 October 2020

File name

Gaviscon Advance Oral Suspension PIL July 20_1602694928.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 20 August 2020

File name

Gaviscon Advance Oral Suspension July20_1597924909.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through pharmacy only

Updated on 15 January 2020

File name

Gaviscon Advance Oral Suspension_1579097050.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 21 July 2015

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Updates made to SmPC to align with current company safety information

Updated on 21 July 2015

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Updated on 20 July 2015

File name

PIL_15986_504.pdf

Reasons for updating

  • New PIL for new product

Updated on 20 July 2015

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to further information section
  • Change to date of revision

Updated on 31 July 2014

Reasons for updating

  • Change to packaging

Updated on 16 April 2014

Reasons for updating

  • New PIL for medicines.ie

Updated on 29 March 2011

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

10 Date of revision of the text

amended from July 2009 to September 2009 (to relfect that of schedule)

Updated on 03 September 2009

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 6.1 - List of excipients
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

  • Section 2: Dosage per 5ml and 1ml added
  • Section 4.2: Extra instructions added, If symptoms do not improve...
  • Section 4.4: Statement deleted, If symptoms do not improve...
  • Section 4.6: Delete statement about limiting treatment
  • Section 4.7:statement updated
  • Section 5.2: PK properties updated
  • Section 6.1:Sodium Hydroxide (for pH adjustment)
  • Section 6.5: nature of container contents updated
  • Section 6.6: waste diposal istructions added

Updated on 15 May 2007

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.3 - Contraindications
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 6.1 - List of excipients
  • Change to section 6.3 - Shelf life
  • Change to marketing authorisation holder address

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

SECTION 1.  Name of medicinal product changed to Gaviscon Advance Oral Suspension.
 
SECTION 2.  Excipients: methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) added to this section.
 
SECTION 4.1.  Wording of therapeutic indications modified.
 
SECTION 4.3  Contraindications wording modified.
 
SECTION 4.6.  Additional recommendation added to pregnancy and lactation section to limit treatment duration as much as possible due to presence of calcium carbonate.
 
SECTION 6.1.  Ingredients of fennel flavour added:  fennel anethol and benzyl alcohol.
 
SECTION 6.3  Shelf life after opening extended to 6 months.
 
SECTION 7.  Change of address of marketing authorisation holder to: 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Updated on 30 June 2005

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Updated on 10 August 2004

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through pharmacy only

Updated on 16 June 2003

Reasons for updating

  • New SPC for medicines.ie

Legal category:Supply through pharmacy only